Vector Capital, a leading private equity firm specializing in transformational investments in established technology businesses, today announced that it has successfully closed its previously announced $100m minority investment in Malwarebytes, a global leader in real-time cyber protection.
In connection with the closing, Vector Capital Managing Directors Sandy Gill and Dave Fishman have joined the company’s Board of Directors.
“Vector Capital is a premier technology investor with a proven track record of building successful businesses, and we are thrilled to have them as a partner as we execute on our mission to create a safer digital world,” said Marcin Kleczynski, co-Founder and Chief Executive Officer of Malwarebytes. “We look forward to drawing on the firm’s significant resources as we seek to accelerate the rollout of new products and features designed to simplify cyber protection for consumers and corporations worldwide.”
Get the week’s top news delivered directly to your inbox – Sign up for our newsletter
“We are excited to invest in Malwarebytes, a global leader in cyber remediation and protection, and support the company through its next phase of growth,” said Sandy Gill, Managing Director at Vector Capital. “As cyber threats continue to increase in frequency and sophistication, we believe Malwarebytes’ products and services are more critical than ever. We look forward to working closely with Marcin and his team to drive innovation, capture greater market share, and capitalize on the many opportunities ahead.”
Paul Hastings LLP acted as legal counsel for Vector Capital. Fenwick & West LLP acted as legal counsel for Malwarebytes and Jefferies LLC acted as its exclusive financial advisor.
Source: Business Wire
Can’t stop reading? Read more
Restructuring wave draws hedge fund interest in French PE-backed firms
Restructuring wave draws hedge fund interest in French PE-backed firms Hedge funds are circling a...
Inflexion exits control of Medik8 as L’Oréal deepens premium skincare push
Inflexion exits control of Medik8 as L’Oréal deepens premium skincare push L’Oréal has agreed to...
Exclusive Interview: Andrei Gemeneanu on building Romania’s private equity future
Exclusive Interview: Andrei Gemeneanu on building Romania's private equity future Andrei...